Approval for Remicade Biosimilar Products Reported to PAFSC’s Second Committee

The health ministry reported the approval of two Remicade (infliximab) biosimilar products to the Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs, an advisory body to the health minister, on May 26. The products, Infliximab BS IV...read more